Oorsprong van het eerstegraads netwerk van Paul Stephen Davit
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Paul Stephen Davit via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BARNES & NOBLE, INC. | Specialty Stores | General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Rochester Christian University | College/University | Undergraduate Degree Undergraduate Degree | |
| GLOBALSCAPE, INC. | Packaged Software | Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman | |
| RESVERLOGIX CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
SWMF Life Science Venture Fund LP
 SWMF Life Science Venture Fund LP Investment ManagersFinance SWMF Life Science Venture Fund LP invests in life science and medical device companies located in Southwest Michigan. It provides financing for start-up and early stage capital requirements. | Investment Managers | Chairman | |
| Icahn Capital LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| ARATANA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Sarissa Capital Management LP
 Sarissa Capital Management LP Investment ManagersFinance Sarissa Capital Management LP (Sarissa) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2012 by Alexander Denner and Mayuran Sriskandarajah. Sarissa provides investment advisory services to pooled investment vehicles operating as private investment funds. | Investment Managers | Chief Executive Officer Founder | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Corporate Officer/Principal Masters Business Admin | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| Seton Hall University | College/University | Undergraduate Degree Undergraduate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Miscellaneous Commercial Services | Founder | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chairman | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 30 |
| Zwitserland | 4 |
| Verenigd Koninkrijk | 4 |
| Denemarken | 4 |
| Frankrijk | 3 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 7 |
| Commercial Services | 7 |
| Finance | 5 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 131 |
| Corporate Officer/Principal | 77 |
| Independent Dir/Board Member | 39 |
| Chairman | 33 |
| Chief Tech/Sci/R&D Officer | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Arthur Higgins | 29 |
| Alexander Denner | 25 |
| Craig Tooman | 22 |
| Richard Mulligan | 19 |
| Norman Hardman | 15 |
| Jeffrey H. Buchalter | 15 |
| Bruce Williams | 14 |
| Bob C. Salisbury | 14 |
| Ivan D. Horak | 13 |
| Richard Young | 12 |
| Rosina B. Dixon | 12 |
| Kenneth Zuerblis | 12 |
| Ulrich Grau | 12 |
| Eric J. Liebler | 12 |
- Beurs
- Insiders
- Paul Stephen Davit
- Bedrijfsconnecties
